This is Comparative Study in Normal Healthy Subjects to Evaluate Pharmacokinetics, Safety, Tolerability of Bmab 1200 -Autoinjector (AI) After Single Subcutaneous Injection (45 mg) in Comparison With Bmab 1200 -Prefilled Syringe (PFS).

Clinical trial NCT06738277 · COMPLETED

Trial details

NCT number: NCT06738277
Sponsor: Biocon Biologics UK Ltd
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Moderate to Severe Chronic Plaque Psoriasis

Start date: 2025-01-09
Primary completion: 2025-07-12
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.